Chapter 1 History of Research on Pathogenesis of Idiopathic Nephrotic Syndrome

Chapter 2 Hemopexin in Minimal Change Nephrotic Syndrome

Chapter 4 Co-stimulatory Molecule CD80 (B7.1) in MCNS

Chapter 5 Energy and Mammalian Target of Rapamycin Complex 1 (mTORC1) in Minimal Change Nephrotic Syndrome

Chapter 6 The Role of c-mip in the Pathogenesis of Minimal Change Nephrotic Syndrome

Chapter 7 Regulatory T Cells and Oxidative Stress in Minimal Change Nephropathy

Chapter 8 Cytokines as Active Factors in Minimal Change Nephrotic Syndrome

Chapter 9 Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis

Chapter 10 Cytokines as Active Factors in Focal Segmental Glomerulosclerosis

Chapter 11 M-type Phospholipase A2 Receptor (PLA2R) and Thrombospondin Type-1 Domain-Containing 7A (THSD7A) in Membranous Nephropathy

Chapter 12 Cationic Bovine Serum Albumin as Cause of Membranous Nephropathy: From Mice to Men

Chapter 13 Podocytes as a Direct Target of Drugs Used in Idiopathic Nephrotic Syndrome